229 related articles for article (PubMed ID: 30829880)
1. Effects of Varying Intranasal Treatment Regimens in ST266-Mediated Retinal Ganglion Cell Neuroprotection.
Khan RS; Dine K; Wessel H; Brown L; Shindler KS
J Neuroophthalmol; 2019 Jun; 39(2):191-199. PubMed ID: 30829880
[TBL] [Abstract][Full Text] [Related]
2. RGC Neuroprotection Following Optic Nerve Trauma Mediated By Intranasal Delivery of Amnion Cell Secretome.
Grinblat GA; Khan RS; Dine K; Wessel H; Brown L; Shindler KS
Invest Ophthalmol Vis Sci; 2018 May; 59(6):2470-2477. PubMed ID: 29847652
[TBL] [Abstract][Full Text] [Related]
3. Intranasal Delivery of A Novel Amnion Cell Secretome Prevents Neuronal Damage and Preserves Function In A Mouse Multiple Sclerosis Model.
Khan RS; Dine K; Bauman B; Lorentsen M; Lin L; Brown H; Hanson LR; Svitak AL; Wessel H; Brown L; Shindler KS
Sci Rep; 2017 Jan; 7():41768. PubMed ID: 28139754
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection mediated by ST266 requires full complement of proteins secreted by amnion-derived multipotent progenitor cells.
Willett K; Khan RS; Dine K; Wessel H; Kirshner ZZ; Sauer JL; Ellis A; Brown LR; Shindler KS
PLoS One; 2021; 16(1):e0243862. PubMed ID: 33406093
[TBL] [Abstract][Full Text] [Related]
5. Amnion-Derived Multipotent Progenitor Cells Suppress Experimental Optic Neuritis and Myelitis.
Khan RS; Ross AG; Willett K; Dine K; Banas R; Brown LR; Shindler KS
Neurotherapeutics; 2021 Jan; 18(1):448-459. PubMed ID: 33067748
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 and NRF2 Gene Transfer Mediate Distinct Neuroprotective Effects Upon Retinal Ganglion Cell Survival and Function in Experimental Optic Neuritis.
McDougald DS; Dine KE; Zezulin AU; Bennett J; Shindler KS
Invest Ophthalmol Vis Sci; 2018 Mar; 59(3):1212-1220. PubMed ID: 29494741
[TBL] [Abstract][Full Text] [Related]
7. HE3286 reduces axonal loss and preserves retinal ganglion cell function in experimental optic neuritis.
Khan RS; Dine K; Luna E; Ahlem C; Shindler KS
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5744-51. PubMed ID: 25139738
[TBL] [Abstract][Full Text] [Related]
8. Calpain inhibition reduces structural and functional impairment of retinal ganglion cells in experimental optic neuritis.
Smith AW; Rohrer B; Wheless L; Samantaray S; Ray SK; Inoue J; Azuma M; Banik NL
J Neurochem; 2016 Oct; 139(2):270-284. PubMed ID: 27513991
[TBL] [Abstract][Full Text] [Related]
9. Intranasal Resveratrol Nanoparticles Enhance Neuroprotection in a Model of Multiple Sclerosis.
Shamsher E; Khan RS; Davis BM; Dine K; Luong V; Cordeiro MF; Shindler KS
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612856
[TBL] [Abstract][Full Text] [Related]
10. Selective Upregulation of SIRT1 Expression in Retinal Ganglion Cells by AAV-Mediated Gene Delivery Increases Neuronal Cell Survival and Alleviates Axon Demyelination Associated with Optic Neuritis.
Ross AG; Chaqour B; McDougald DS; Dine KE; Duong TT; Shindler RE; Yue J; Liu T; Shindler KS
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740955
[TBL] [Abstract][Full Text] [Related]
11. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
Larabee CM; Desai S; Agasing A; Georgescu C; Wren JD; Axtell RC; Plafker SM
Mol Vis; 2016; 22():1503-1513. PubMed ID: 28050123
[TBL] [Abstract][Full Text] [Related]
12. Timing of corticosteroid therapy is critical to prevent retinal ganglion cell loss in experimental optic neuritis.
Dutt M; Tabuena P; Ventura E; Rostami A; Shindler KS
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1439-45. PubMed ID: 19892867
[TBL] [Abstract][Full Text] [Related]
13. Spermidine alleviates severity of murine experimental autoimmune encephalomyelitis.
Guo X; Harada C; Namekata K; Kimura A; Mitamura Y; Yoshida H; Matsumoto Y; Harada T
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2696-703. PubMed ID: 21228387
[TBL] [Abstract][Full Text] [Related]
14. Further Evidence on Efficacy of Diet Supplementation with Fatty Acids in Ocular Pathologies: Insights from the EAE Model of Optic Neuritis.
Locri F; Cammalleri M; Pini A; Dal Monte M; Rusciano D; Bagnoli P
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30301197
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles Enhance Solubility and Neuroprotective Effects of Resveratrol in Demyelinating Disease.
Shamsher E; Khan RS; Davis BM; Dine K; Luong V; Somavarapu S; Cordeiro MF; Shindler KS
Neurotherapeutics; 2023 Jul; 20(4):1138-1153. PubMed ID: 37160530
[TBL] [Abstract][Full Text] [Related]
16. Myelin-specific Th17 cells induce severe relapsing optic neuritis with irreversible loss of retinal ganglion cells in C57BL/6 mice.
Larabee CM; Hu Y; Desai S; Georgescu C; Wren JD; Axtell RC; Plafker SM
Mol Vis; 2016; 22():332-41. PubMed ID: 27122964
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis.
Shindler KS; Ventura E; Dutt M; Rostami A
Exp Eye Res; 2008 Sep; 87(3):208-13. PubMed ID: 18653182
[TBL] [Abstract][Full Text] [Related]
18. Early alpha-lipoic acid therapy protects from degeneration of the inner retinal layers and vision loss in an experimental autoimmune encephalomyelitis-optic neuritis model.
Dietrich M; Helling N; Hilla A; Heskamp A; Issberner A; Hildebrandt T; Kohne Z; Küry P; Berndt C; Aktas O; Fischer D; Hartung HP; Albrecht P
J Neuroinflammation; 2018 Mar; 15(1):71. PubMed ID: 29514678
[TBL] [Abstract][Full Text] [Related]
19. SIRT1 activation confers neuroprotection in experimental optic neuritis.
Shindler KS; Ventura E; Rex TS; Elliott P; Rostami A
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3602-9. PubMed ID: 17652729
[TBL] [Abstract][Full Text] [Related]
20. Brimonidine suppresses loss of retinal neurons and visual function in a murine model of optic neuritis.
Guo X; Namekata K; Kimura A; Noro T; Azuchi Y; Semba K; Harada C; Yoshida H; Mitamura Y; Harada T
Neurosci Lett; 2015 Apr; 592():27-31. PubMed ID: 25736951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
